Kennedy Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Buy |
13,509
+496
| +4% | +$4.65K | ﹤0.01% | 578 |
|
|
2025
Q1 | $92.5K | Buy |
13,013
+166
| +1% | +$1.18K | ﹤0.01% | 640 |
|
|
2024
Q4 | $150K | Buy |
12,847
+2,381
| +23% | +$27.8K | ﹤0.01% | 665 |
|
|
2024
Q3 | $215K | Buy |
+10,466
| New | +$215K | ﹤0.01% | 673 |
|
|
2022
Q2 | – | Sell |
-3,348
| Closed | -$243K | – | 626 |
|
|
2022
Q1 | $243K | Buy |
3,348
+905
| +37% | +$65.7K | 0.01% | 580 |
|
|
2021
Q4 | $289K | Sell |
2,443
-209
| -8% | -$24.7K | 0.01% | 593 |
|
|
2021
Q3 | $356K | Sell |
2,652
-55
| -2% | -$7.38K | 0.01% | 603 |
|
|
2021
Q2 | $438K | Buy |
+2,707
| New | +$438K | 0.01% | 592 |
|